1. |
1 Hjartåker A, Langseth H, Weiderpass E. Obesity and diabetes epidemics: cancer repercussions.
Adv Exp Med Biol
, 2008, 630: 72-93.
|
2. |
2 Chung YC, Chaen YL, Hsu CP. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Anticancer Res
, 2006, 26(5B): 3905-3911.
|
3. |
3 Pellegrini M, Marzocca G. Obesity, insulin-like growth factors and colorectal cancer.
Panminerva Med
, 2006, 48(2): 143-144.
|
4. |
4 Wells GA, Shea B, O’Connell D,
et al
. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. The Ottawa Health Research Institute, 2010.
|
5. |
5 Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity.
Cancer Epidemiol Biomarkers Prev
, 1995, 4(8): 807-811.
|
6. |
6 Will JC, Galuska DA, Vinicor F,
et al
. Colorectal cancer: another complication of diabetes mellitus?
Am J Epidemiol
, 1998, 147(9): 816-825.
|
7. |
7 Hu FB, Manson JE, Liu S,
et al
. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women.
J Natl Cancer Inst
, 1999, 91(6): 542-547.
|
8. |
8 Schoen RE, Tangen CM, Kuller LH,
et al
. Increased blood glucose and insulin, body size, and incident colorectal cancer.
J Natl Cancer Inst
, 1999, 91(13): 1147-1154.
|
9. |
9 Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis.
Br J Cancer
, 2001, 84(3): 417-422.
|
10. |
10 Sandhu MS, Luben R, Khaw KT. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study.
J Epidemiol Community Health
, 2001, 55(11): 804-805.
|
11. |
11 Khaw KT, Wareham N, Bingham S,
et al
. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study.
Cancer Epidemiol Biomarkers Prev
, 2004, 13(6): 915-919.
|
12. |
12 Limburg PJ, Anderson KE, Johnson TW,
et al
. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.
Cancer Epidemiol Biomarkers Prev
, 2005, 14(1): 133-137.
|
13. |
13 Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men.
Diabetes Care
, 2005, 28(7): 1805-1807.
|
14. |
14 Seow A, Yuan JM, Koh WP,
et al
. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study.
J Natl Cancer Inst
, 2006, 98(2): 135-138.
|
15. |
15 Inoue M, Iwasaki M, Otani T,
et al
. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.
Arch Intern Med
, 2006, 166(17): 1871-1877.
|
16. |
16 Ahmed RL, Schmitz KH, Anderson KE,
et al
. The metabolic syndrome and risk of incident colorectal cancer.
Cancer
, 2006, 107(1): 28-36.
|
17. |
17 Bowers K, Albanes D, Limburg P,
et al
. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers.
Am J Epidemiol
, 2006, 164(7): 652-664.
|
18. |
18 Stürmer T, Buring JE, Lee IM,
et al
. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study.
Cancer Epidemiol Biomarkers Prev
, 2006, 15(12): 2391-2397.
|
19. |
19 Ogunleye AA, Ogston SA, Morris AD,
et al
. A cohort study of the risk of cancer associated with type 2 diabetes.
Br J Cancer
, 2009, 101(7): 1199-1201.
|
20. |
20 Flood A, Strayer L, Schairer C,
et al
. Diabetes and risk of incident colorectal cancer in a prospective cohort of women.
Cancer Causes Control
, 2010, 21(8): 1277-1284.
|
21. |
21 He J, Stram DO, Kolonel LN,
et al
. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort.
Br J Cancer
, 2010, 103(1): 120-126.
|
22. |
22 Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer.
Obes Rev
, 2009, 10(6): 610-616.
|
23. |
23 Jin T. Why diabetes patients are more prone to the development of colon cancer?
Med Hypotheses
, 2008, 71(2): 241-244.
|
24. |
24 Pais R, Silaghi H, Silaghi AC,
et al
. Metabolic syndrome and risk of subsequent colorectal cancer.
World J Gastroenterol
, 2009, 15(41): 5141-5148.
|
25. |
25 Siddiqui AA. Metabolic syndrome and its association with colorectal cancer: a review.
Am J Med Sci
, 2011, 341(3):227-231.
|
26. |
26 Pelucchi C, Negri E, Talamini R,
et al
. Metabolic syndrome is associated with colorectal cancer in men.
Eur J Cancer
, 2010, 46(10): 1866-1872.
|
27. |
27 Schiel R, Müller UA, Braun A,
et al
. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
Eur J Med Res
, 2005, 10(8): 339-344.
|
28. |
28 Nicolucci A. Epidemiological aspects of neoplasms in diabetes.
Acta Diabetol
, 2010, 47(2): 87-95.
|
29. |
29 Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer.
Oncogene
, 2010, 29(6): 781-788.
|
30. |
30 Malicki S, Winiarski M, Matlok M,
et al
. IL-6 and IL-8 responses of colorectal cancer in vivo and in vitro cancer cells subjected to simvastatin.
J Physiol Pharmacol
, 2009, 60(4): 141-146.
|
31. |
31 Lee MS, Hsu CC, Wahlqvist ML,
et al
. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
BMC Cancer
, 2011, 11: 20.
|
32. |
32 Zhao G, Ford ES, Ahluwalia IB,
et al
. Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes.
J Gen Intern Med
, 2009, 24(2): 270-275.
|
33. |
33 Giouleme O, Diamantidis MD, Katsaros MG. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.
World J Gastroenterol
, 2011, 17(4): 444-448.
|
34. |
34 Campbell PT, Deka A, Jacobs EJ,
et al
. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men.
Gastroenterology
, 2010, 139(4): 1138-1146.
|
35. |
35 Rensing KL, Houttuijn Bloemendaal FM, Weijers EM,
et al
. Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
Diabetologia
, 2010, 53(5): 966-970.
|